Jennifer Buell - Sep 9, 2025 Form 4/A - Amendment Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Chief Executive Officer
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Stock symbol
INKT
Transactions as of
Sep 9, 2025
Transactions value $
-$82,191
Form type
4/A - Amendment
Date filed
10/3/2025, 04:05 PM
Date Of Original Report
Sep 11, 2025
Previous filing
May 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Buell Jennifer Chief Executive Officer 149 FIFTH AVENUE, SUITE 500, NEW YORK By: /s/ Christine Klaskin, Attorney-in-Fact 2025-10-03 0001711184

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Tax liability -$82.2K -5.35K -12.79% $15.36 36.5K Sep 9, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld for payment of the withholding taxes in relation to the stock issued to reporting person on September 9, 2025, as previously reported on the Form 4 filed on September 11, 2025 (the "Original Form 4"). The Original Form 4 did not include the shares withheld for payment of withholding taxes in Table I. This amendment is being filed to correct this error.